Managers / Q2 2023 · view latest →
MADDEN SECURITIES Corp
CIK 0001803566 · 8333 DOUGLAS AVENUE, SUITE 1625, DALLAS, TX, 75225 · (214) 855-5335
Summary
Madden Securities Corp reported $195M in U.S.-listed holdings across 87 positions for Q2 2023.
Its largest position, J P Morgan Exchange Traded F, represents 6.4% of the portfolio.
Compared with Q1 2023, the fund opened 6 new positions and exited 8.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 65.6% · $128M
- ETP · 26.4% · $52M
- REIT · 4.2% · $8M
- Other · 2.3% · $5M
- MLP · 0.9% · $2M
- Other · 0.6% · $1M
Quarter-over-Quarter Changes full breakdown →
vs Q1 2023 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| ARANTERO RESOURCES CORP | NEW | +138.3K | 138.3K | +$3M | $3M |
| ALBALBEMARLE CORP | NEW | +8.1K | 8.1K | +$2M | $2M |
| SPDR SER TR | NEW | +25.9K | 25.9K | +$1M | $1M |
| UNHUNITEDHEALTH GROUP INC | NEW | +533 | 533 | +$256,181 | $256,181 |
| ORCLORACLE CORP | NEW | +1.8K | 1.8K | +$211,980 | $211,980 |
| VANGUARD SPECIALIZED FUNDS | NEW | +1.3K | 1.3K | +$203,129 | $203,129 |
| CVSCVS HEALTH CORP | ADDED | +44.8K | 49.8K | +$3M | $3M |
| CMACOMERICA INC | ADDED | +94.4K | 141.4K | +$4M | $6M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2023
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $333M | 113 | May 5, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $328M | 115 | Feb 4, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $327M | 112 | Oct 24, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $298M | 107 | Jul 23, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $258M | 116 | Apr 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $250M | 110 | Jan 29, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $232M | 106 | Oct 10, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $226M | 103 | Jul 11, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $217M | 96 | Apr 10, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $189M | 93 | Feb 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $177M | 85 | Oct 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $195M | 87 | Jul 6, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $189M | 89 | Apr 21, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $190M | 395 | Jan 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $166M | 97 | Oct 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $182M | 99 | Aug 4, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $222M | 121 | Apr 28, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $213M | 111 | Jan 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $185M | 109 | Oct 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $191M | 137 | Jul 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $171M | 132 | Apr 30, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $155M | 128 | Jan 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $135M | 112 | Oct 8, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $112M | 98 | Jul 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $100M | 111 | Feb 25, 2020 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.